Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.44 |
| ▸ | LPL | P06858 | 13/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31757597 | 0.92 | LIPG (0.46) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL11978734 | 0.92 | LIPG (0.46) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL31187004 | 0.92 | LIPG (0.46) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL23868765 | 0.88 | LIPG (0.50) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL23868914 | 0.82 | LIPG (0.46) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL22947506 | 0.81 | LIPG (0.56) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL23869291 | 0.81 | LIPG (0.46) | LIPGLPLIRAK4P4HB | |
| SCHEMBL23869201 | 0.80 | LIPG (0.45) | LIPGLPLIRAK4P4HB | |
| SCHEMBL16735446 | 0.78 | LIPG (0.40) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL22947447 | 0.78 | LIPG (0.45) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10559756-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-02-11 | — | — | US | disclosed |
| US-20160254456-A1 | Materials for Electronic Devices | MERCK PATENT GMBH (DE) | 2016-09-01 | — | — | US | disclosed |
| US-20160254456-A1 | Materials for Electronic Devices | MERCK PATENT GMBH (DE) | 2016-09-01 | — | — | US | disclosed |
| US-20140378416-A1 | SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. | 2014-12-25 | — | — | US | disclosed |
| US-20140378416-A1 | SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. | 2014-12-25 | — | — | US | disclosed |
| WO-2014111269-A2 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2014-07-24 | — | — | WO | disclosed |
| US-20130245211-A1 | ORGANIC SEMICONDUCTOR MATERIALS, PREPARATION METHODS AND APPLICATIONS THEREOF | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2013-09-19 | — | — | US | disclosed |
| US-20130245211-A1 | ORGANIC SEMICONDUCTOR MATERIALS, PREPARATION METHODS AND APPLICATIONS THEREOF | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2013-09-19 | — | — | US | disclosed |
| WO-2013039876-A1 | SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2013-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160254456-A1 | Materials for Electronic Devices | FHIT, TEC, EED | LIPG 3221/4885LPL 4328/4885CA1 3350/4885 |
| US-20140378416-A1 | SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | ZC3HAV1L, HBS1L, HAVCR2 | LIPG 1563/4885LPL 759/4885CA1 3408/4885 |
| US-10559756-B2 | Materials for electronic devices | TEC, EFNA1, BMI1 | LIPG 3626/4885LPL 4510/4885CA1 3105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.